NZ185341A - 19-oxygenated steroids and pharmaceutical compositions - Google Patents

19-oxygenated steroids and pharmaceutical compositions

Info

Publication number
NZ185341A
NZ185341A NZ185341A NZ18534177A NZ185341A NZ 185341 A NZ185341 A NZ 185341A NZ 185341 A NZ185341 A NZ 185341A NZ 18534177 A NZ18534177 A NZ 18534177A NZ 185341 A NZ185341 A NZ 185341A
Authority
NZ
New Zealand
Prior art keywords
pharmaceutical compositions
oxygenated steroids
oxygenated
steroids
pharmaceutical
Prior art date
Application number
NZ185341A
Other languages
English (en)
Inventor
M Biollaz
H Ueberwasser
G Anner
P Wieland
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU75936A external-priority patent/LU75936A1/xx
Priority claimed from LU76966A external-priority patent/LU76966A1/xx
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NZ185341A publication Critical patent/NZ185341A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/007—3 membered carbocyclic rings in position 6-7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/005—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C07J33/007—Cyclic thioketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ185341A 1976-10-05 1977-10-04 19-oxygenated steroids and pharmaceutical compositions NZ185341A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU75936A LU75936A1 (en:Method) 1976-10-05 1976-10-05
LU76966A LU76966A1 (en:Method) 1977-03-17 1977-03-17

Publications (1)

Publication Number Publication Date
NZ185341A true NZ185341A (en) 1979-06-19

Family

ID=26640214

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ185341A NZ185341A (en) 1976-10-05 1977-10-04 19-oxygenated steroids and pharmaceutical compositions

Country Status (16)

Country Link
US (1) US4150127A (en:Method)
JP (1) JPS5346952A (en:Method)
AT (1) ATA705277A (en:Method)
AU (1) AU512101B2 (en:Method)
CA (1) CA1099701A (en:Method)
DD (1) DD132349A5 (en:Method)
DE (1) DE2744255A1 (en:Method)
DK (1) DK142707B (en:Method)
ES (1) ES462882A1 (en:Method)
FI (1) FI58779C (en:Method)
FR (1) FR2367079A1 (en:Method)
IL (1) IL53058A0 (en:Method)
NL (1) NL7710939A (en:Method)
NO (1) NO773381L (en:Method)
NZ (1) NZ185341A (en:Method)
SE (1) SE7711094L (en:Method)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259240A (en) * 1979-09-28 1981-03-31 Advance Biofactures Corporation Synthesis of furyl intermediates, and cardenolides and their isomers prepared therefrom
DE3326013A1 (de) * 1983-07-15 1985-01-24 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-methylen-17(alpha)-pregna-4,6-dien-21-carbonsaeuresalze, diese enthaltende pharmazeutische praeparate sowie verfahren zu deren herstellung
DE3330084A1 (de) * 1983-08-17 1985-03-07 Schering AG, 1000 Berlin und 4709 Bergkamen 7(alpha)-alkoxycarbonyl-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone und deren 21-carbonsaeuresalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
JPH0425327Y2 (en:Method) * 1985-11-08 1992-06-17
FR2656309B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveaux produits sterouides comportant en position 10, un radical ethyle substitue, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
DE69519368T2 (de) * 1994-01-06 2001-03-08 Sri International, Menlo Park Neue antiandrogenen mitteln pharmazeutische präparate und verwendungen davon
WO2012107513A1 (en) * 2011-02-10 2012-08-16 Crystal Pharma, S.A.U. Process for obtaining drospirenone
CH708607A2 (fr) 2013-09-26 2015-03-31 Montres Breguet Sa Pièce d'horlogerie musicale ou à sonnerie.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058522A (en) * 1973-07-09 1977-11-15 Richter Gedeon Vegyeszeti Gyar Rt. Steroids effective against heavy-metal poisoning
US4028348A (en) * 1976-02-17 1977-06-07 Richter Gedeon Vegyeszeti Gyar Rt 6-Amino-5β,19-cycloandrostane derivatives

Also Published As

Publication number Publication date
SE7711094L (sv) 1978-04-06
ATA705277A (de) 1981-07-15
NO773381L (no) 1978-04-06
FR2367079B1 (en:Method) 1980-04-18
CA1099701A (en) 1981-04-21
AU512101B2 (en) 1980-09-25
FI772900A7 (fi) 1978-04-06
DE2744255A1 (de) 1978-04-06
FI58779C (fi) 1981-04-10
FI58779B (fi) 1980-12-31
AU2932577A (en) 1979-04-12
IL53058A0 (en) 1977-12-30
JPS5346952A (en) 1978-04-27
US4150127A (en) 1979-04-17
ES462882A1 (es) 1978-12-16
FR2367079A1 (fr) 1978-05-05
DK438577A (en:Method) 1978-04-06
DK142707B (da) 1980-12-29
NL7710939A (nl) 1978-04-07
DK142707C (en:Method) 1981-10-05
DD132349A5 (de) 1978-09-20

Similar Documents

Publication Publication Date Title
ZA771998B (en) Triazolo-pyrimidines and pharmaceutical compositions containing them
IL51816A0 (en) Novel steroids their preparation and pharmaceutical compositions containing them
NZ185986A (en) 2-oxa-bicyclic prostag-landins and pharmaceutical compositions
NZ185356A (en) 1-aryloxy-2-hydroxy-3-alkyleneaminopropanes and pharmaceutical compositions containing them
NZ183551A (en) Aminochromanols and pharmaceutical compositions containingthem
NZ185358A (en) Spiro-hydantoins and pharmaceutical compositions
NZ183150A (en) 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions
NZ183134A (en) I-i-(3-aryloxy-2-hydroxypropyl)-4-piperidyl-3-aryl-imid-azolidin or hexahydropyrimidin-2-ones; and pharmaceutical compositions
JPS5262263A (en) Esteranic steroid and pharmaceutical composition thereof
NZ184428A (en) N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions
NZ184755A (en) 2-benzylpyrrolidine derivatives and pharmaceutical compositions
NZ184912A (en) 2-phenylamino-imidazolines and pharmaceutical compositions
NZ185642A (en) Morphanthridine derivatives and pharmaceutical compositions
IL52433A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine and pharmaceutical compositions containing them
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
NZ184103A (en) Fenzodioxole derivatives and pharmaceutical compositions
NZ184735A (en) Peptides and pharmaceutical compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ183549A (en) Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions
NZ185341A (en) 19-oxygenated steroids and pharmaceutical compositions
NZ185296A (en) Corticoids and pharmaceutical compositions
PH12590A (en) 4a-aryl octahydro-1h-2-pyrindines and pharmaceutical composition thereof
IL52409A0 (en) 5-m-tolyloxyuracil and pharmaceutical compositions containing it
JPS5320433A (en) Pharmaceutical composition and application